Clinical trial

RCT of ChondroCelect® (in an ACI Procedure) vs Microfracture in the Repair of…

NCT00414700 · TiGenix n.v., Industry · Completed

Key facts

NCT number NCT00414700
Title RCT of ChondroCelect® (in an ACI Procedure) vs Microfracture in the Repair of Cartilage Defects of the Knee
Official title Prospective Multicenter Randomized Controlled Trial of ChondroCelect® (Via Autologous Chondrocyte Implantation) vs Microfracture (as Procedure) in the Repair of Symptomatic Cartilaginous Defects of the Femoral Condyles
Acronym TIGACT01
Lead sponsor TiGenix n.v., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Articular Cartilage Lesion of the Femoral Condyle
Intervention type Drug, Procedure
Interventions ChondroCelect implantation, Microfracture
Enrollment 118
Start date Feb 1, 2002
Primary completion Jul 1, 2006
Completion Jan 1, 2010
First posted Dec 22, 2006
Last update posted Sep 26, 2011
Countries Belgium, Croatia, Germany, Netherlands

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies